Alessandro Riva

Alessandro Riva

Chief Executive Officer bij TRANSGENE

Vermogen: 949 786 $ op 29-02-2024

63 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Alessandro Riva founded Cancer International Research Group and Breast Cancer International Research Group Ltd.
Presently, Dr. Riva is Chief Executive Officer of Intima Bioscience, Inc. and Chairman & Chief Executive Officer of Transgene SA. Dr. Riva is also on the board of BeiGene Ltd.
and Century Therapeutics, Inc. In the past Alessandro Riva held the position of Director at Ichnos Sciences, Inc., Executive VP-Oncology Therapeutics at Gilead Sciences, Inc., VP, Head-Oncology Development & Medical Affairs at Novartis AG President at Novartis Oncology, Inc. and EVP, Head-Oncology Development & Medical Affairs at Novartis Pharmaceuticals Corp.
(both are subsidiaries of Novartis AG) and Chief Executive Officer-Innovation Business at Glenmark Pharmaceuticals Ltd.
He received a doctorate and an undergraduate degree from the University of Milan.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-06-2023 70 148 ( 0.01% ) 949 786 $ 29-02-2024
27-06-2023 0 ( -.--% ) - $ 29-02-2024

Actieve functies van Alessandro Riva

BedrijvenFunctieBegin
BEIGENE, LTD. Director/Board Member 01-02-2022
CENTURY THERAPEUTICS, INC. Director/Board Member 01-05-2021
TRANSGENE Chief Executive Officer 01-06-2023
Chief Executive Officer 01-09-2021
Alle actieve functies van Alessandro Riva

Eerdere bekende functies van Alessandro Riva

BedrijvenFunctieEinde
Chief Executive Officer 21-05-2021
GILEAD SCIENCES, INC. Corporate Officer/Principal 06-03-2019
NOVARTIS AG Corporate Officer/Principal 01-12-2016
President 01-01-2016
Corporate Officer/Principal 01-01-2016
Ervaring van Alessandro Riva in detail bekijken

Opleiding van Alessandro Riva

University of Milan Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Alessandro Riva in detail bekijken

Connecties

97

Eerstegraads connecties

14

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven6
GILEAD SCIENCES, INC.

Health Technology

TRANSGENE

Health Technology

NOVARTIS AG

Health Technology

GLENMARK PHARMACEUTICALS LIMITED

Health Technology

BEIGENE, LTD.

Health Technology

CENTURY THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit7

Health Technology

Health Technology

Breast Cancer International Research Group Ltd.

Health Technology

Commercial Services

Health Technology

Cancer International Research Group

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Alessandro Riva